| |  Online-Ressource |
|---|
| Verfasst von: | Giesen, Nicola [VerfasserIn]  |
|---|
| | Busch, Elena [VerfasserIn] |
|---|
| | Schalk, Enrico [VerfasserIn] |
|---|
| | Beutel, Gernot [VerfasserIn] |
|---|
| | Rüthrich, Maria Madeleine [VerfasserIn] |
|---|
| | Hentrich, Marcus [VerfasserIn] |
|---|
| | Hertenstein, Bernd [VerfasserIn] |
|---|
| | Hirsch, Hans H. [VerfasserIn] |
|---|
| | Karthaus, Meinolf [VerfasserIn] |
|---|
| | Khodamoradi, Yascha [VerfasserIn] |
|---|
| | Köhler, Philipp [VerfasserIn] |
|---|
| | Krüger, William H. [VerfasserIn] |
|---|
| | Koldehoff, Michael [VerfasserIn] |
|---|
| | Krause, Robert [VerfasserIn] |
|---|
| | Mellinghoff, Sibylle Christiane [VerfasserIn] |
|---|
| | Penack, Olaf [VerfasserIn] |
|---|
| | Sandherr, Michael [VerfasserIn] |
|---|
| | Seggewiß-Bernhardt, Ruth [VerfasserIn] |
|---|
| | Spiekermann, Karsten [VerfasserIn] |
|---|
| | Sprute, Rosanne [VerfasserIn] |
|---|
| | Stemler, Jannik [VerfasserIn] |
|---|
| | Weißinger, Florian [VerfasserIn] |
|---|
| | Wörmann, Bernhard [VerfasserIn] |
|---|
| | Wolf, Hans-Heinrich [VerfasserIn] |
|---|
| | Cornely, Oliver Andreas [VerfasserIn] |
|---|
| | Rieger, Christina [VerfasserIn] |
|---|
| | Lilienfeld-Toal, Marie von [VerfasserIn] |
|---|
| Titel: | AGIHO guideline on evidence-based management of COVID-19 in cancer patients |
|---|
| Titelzusatz: | 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants |
|---|
| Verf.angabe: | Nicola Giesen, Elena Busch, Enrico Schalk, Gernot Beutel, Maria M. Rüthrich, Marcus Hentrich, Bernd Hertenstein, Hans H. Hirsch, Meinolf Karthaus, Yascha Khodamoradi, Philipp Koehler, William Krüger, Michael Koldehoff, Robert Krause, Sibylle C. Mellinghoff, Olaf Penack, Michael Sandherr, Ruth Seggewiss-Bernhardt, Karsten Spiekermann, Rosanne Sprute, Jannik Stemler, Florian Weissinger, Bernhard Wörmann, Hans-Heinrich Wolf, Oliver A. Cornely, Christina T. Rieger, Marie von Lilienfeld-Toal |
|---|
| E-Jahr: | 2023 |
|---|
| Jahr: | 16 January 2023 |
|---|
| Umfang: | 17 S. |
|---|
| Fussnoten: | Online verfügbar 10. Dezember 2022, Artikelversion März 2023 ; Gesehen am 06.04.2023 |
|---|
| Titel Quelle: | Enthalten in: European journal of cancer |
|---|
| Ort Quelle: | Amsterdam [u.a.] : Elsevier, 1965 |
|---|
| Jahr Quelle: | 2023 |
|---|
| Band/Heft Quelle: | 181(2023), Seite 102-118 |
|---|
| ISSN Quelle: | 1879-0852 |
|---|
| Abstract: | The novel coronavirus SARS-CoV-2 and the associated infectious disease COVID-19 pose a significant challenge to healthcare systems worldwide. Patients with cancer have been identified as a high-risk population for severe infections, rendering prophylaxis and treatment strategies for these patients particularly important. Rapidly evolving clinical research, resulting in the recent advent of various vaccines and therapeutic agents against COVID-19, offers new options to improve care and protection of cancer patients. However, ongoing epidemiological changes and rise of new virus variants require repeated revisions and adaptations of prophylaxis and treatment strategies to meet these new challenges. Therefore, this guideline provides an update on evidence-based recommendations with regard to vaccination, pharmacological prophylaxis and treatment of COVID-19 in cancer patients in light of the currently dominant omicron variants. It was developed by an expert panel of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) based on a critical review of the most recent available data. |
|---|
| DOI: | doi:10.1016/j.ejca.2022.11.030 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
kostenfrei: Resolving-System: https://doi.org/10.1016/j.ejca.2022.11.030 |
|---|
| | Volltext: https://www.sciencedirect.com/science/article/pii/S0959804922017804 |
|---|
| | DOI: https://doi.org/10.1016/j.ejca.2022.11.030 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | Cancer |
|---|
| | COVID-19 |
|---|
| | Guideline |
|---|
| | Haematological malignancy |
|---|
| | Prophylaxis |
|---|
| | SARS-CoV-2 |
|---|
| | Solid tumour |
|---|
| | Treatment |
|---|
| | Vaccination |
|---|
| K10plus-PPN: | 1841874140 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
AGIHO guideline on evidence-based management of COVID-19 in cancer patients / Giesen, Nicola [VerfasserIn]; 16 January 2023 (Online-Ressource)
Zurück zur Trefferübersicht und Suche
